tiprankstipranks

Suma Krishnan Insider Profile

4 Followers
Suma Krishnan, President, R&D, Director, Ten Percent Owner at Krystal Biotech, holds 1.49M shares in Krystal Biotech (Ticker: KRYS), holds 113.31K shares in Precigen (Ticker: PGEN).
tipranks
Suma Krishnan

Suma Krishnan
Krystal Biotech (KRYS)
President, R&D, Director, Ten Percent Owner

Ranked #7,787 out of 108,921 Corporate Insiders

Profitable Transactions

40%
4 out of 10 Profitable Transactions

Average Return

+29.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$536M
99.85%
0.15%
A breakdown of Suma Krishnan's holdings

Insider Roles

Krystal Biotech
(KRYS)
President, R&D, Director, Ten Percent Owner
Precigen
(PGEN)
SVP--Product Development
Roles that Suma Krishnan holds in companies

Most Profitable Insider Trade

Stock:
Precigen
(PGEN)
Rating:Informative Buy
Date:May 13, 2014 - May 13, 2015
Return:+170.70%
The most profitable trade made by Suma Krishnan

Suma Krishnan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Krystal Biotech
Sep 04, 2026
President, R&D, Director, Ten Percent Owner
Uninformative Sell
184.36K
$534.91M
Precigen
Feb 01, 2016
SVP--Product Development
Uninformative Buy
201.68K
$804.53K
List of latest transactions for each holding click on a transaction to see Suma Krishnan's performance on stock

Suma Krishnan insider profile FAQ

What is the percentage of profitable transactions made by Suma Krishnan?
The percentage of profitable transactions made by Suma Krishnan is 40%.
    What is the average return per transaction made by Suma Krishnan?
    The average return per transaction made by Suma Krishnan is 29.00%.
      What stocks does Suma Krishnan hold?
      Suma Krishnan holds: KRYS, PGEN stocks.
        What was Suma Krishnan’s latest transaction?
        Suma Krishnan latest transaction was an Uninformative Sell of $184.36K.
          What was Suma Krishnan's most profitable transaction?
          Suma Krishnan’s most profitable transaction was an Informative Buy of PGEN stock on May 13, 2014. The return on the trade was 170.70%.
            What is Suma Krishnan's role in Krystal Biotech?
            Suma Krishnan's role in Krystal Biotech is President, R&D, Director, Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.